2-Propenoic acid, 3-phenyl-, 3-phenyl-2-propenyl ester

Details

Top
Internal ID 3456ee21-311b-4825-adbb-1bce851bc2ad
Taxonomy Phenylpropanoids and polyketides > Cinnamic acids and derivatives > Cinnamic acid esters
IUPAC Name 3-phenylprop-2-enyl 3-phenylprop-2-enoate
SMILES (Canonical) C1=CC=C(C=C1)C=CCOC(=O)C=CC2=CC=CC=C2
SMILES (Isomeric) C1=CC=C(C=C1)C=CCOC(=O)C=CC2=CC=CC=C2
InChI InChI=1S/C18H16O2/c19-18(14-13-17-10-5-2-6-11-17)20-15-7-12-16-8-3-1-4-9-16/h1-14H,15H2
InChI Key NQBWNECTZUOWID-UHFFFAOYSA-N
Popularity 8 references in papers

Physical and Chemical Properties

Top
Molecular Formula C18H16O2
Molecular Weight 264.30 g/mol
Exact Mass 264.115029749 g/mol
Topological Polar Surface Area (TPSA) 26.30 Ų
XlogP 4.40
Atomic LogP (AlogP) 3.96
H-Bond Acceptor 2
H-Bond Donor 0
Rotatable Bonds 5

Synonyms

Top
DTXSID7047647
CBDivE_001756
CHEMBL3186867
2-Propenoic acid, 3-phenyl-, 3-phenyl-2-propenyl ester; Cinnamic acid, cinnamyl este
AKOS025244100
FT-0623842
D89335

2D Structure

Top
2D Structure of 2-Propenoic acid, 3-phenyl-, 3-phenyl-2-propenyl ester

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 1.0000 100.00%
Caco-2 + 0.7518 75.18%
Blood Brain Barrier + 0.8500 85.00%
Human oral bioavailability - 0.5857 58.57%
Subcellular localzation Mitochondria 0.5764 57.64%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9159 91.59%
OATP1B3 inhibitior + 0.9488 94.88%
MATE1 inhibitior - 0.7800 78.00%
OCT2 inhibitior - 0.8500 85.00%
BSEP inhibitior + 0.8116 81.16%
P-glycoprotein inhibitior - 0.9490 94.90%
P-glycoprotein substrate - 0.9887 98.87%
CYP3A4 substrate - 0.6709 67.09%
CYP2C9 substrate - 0.6000 60.00%
CYP2D6 substrate - 0.8653 86.53%
CYP3A4 inhibition - 0.9594 95.94%
CYP2C9 inhibition - 0.7181 71.81%
CYP2C19 inhibition + 0.6044 60.44%
CYP2D6 inhibition - 0.9271 92.71%
CYP1A2 inhibition + 0.8862 88.62%
CYP2C8 inhibition - 0.6006 60.06%
CYP inhibitory promiscuity + 0.7876 78.76%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.5267 52.67%
Carcinogenicity (trinary) Non-required 0.6683 66.83%
Eye corrosion - 0.7121 71.21%
Eye irritation + 0.9531 95.31%
Skin irritation + 0.5414 54.14%
Skin corrosion - 0.9625 96.25%
Ames mutagenesis + 0.6700 67.00%
Human Ether-a-go-go-Related Gene inhibition - 0.4598 45.98%
Micronuclear - 0.7800 78.00%
Hepatotoxicity - 0.5000 50.00%
skin sensitisation + 0.6679 66.79%
Respiratory toxicity - 0.9000 90.00%
Reproductive toxicity - 0.8111 81.11%
Mitochondrial toxicity - 0.9750 97.50%
Nephrotoxicity - 0.6296 62.96%
Acute Oral Toxicity (c) III 0.8495 84.95%
Estrogen receptor binding + 0.7924 79.24%
Androgen receptor binding + 0.7109 71.09%
Thyroid receptor binding - 0.7847 78.47%
Glucocorticoid receptor binding - 0.7796 77.96%
Aromatase binding + 0.8624 86.24%
PPAR gamma - 0.8544 85.44%
Honey bee toxicity - 0.9301 93.01%
Biodegradation - 0.8000 80.00%
Crustacea aquatic toxicity - 0.5655 56.55%
Fish aquatic toxicity + 0.9906 99.06%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL1293249 Q13887 Kruppel-like factor 5 95.84% 86.33%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 93.81% 96.00%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 91.81% 91.11%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 90.71% 95.56%
CHEMBL221 P23219 Cyclooxygenase-1 89.86% 90.17%
CHEMBL2035 P08912 Muscarinic acetylcholine receptor M5 89.44% 94.62%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 87.08% 96.09%
CHEMBL2288 Q13526 Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 86.88% 91.71%
CHEMBL3060 Q9Y345 Glycine transporter 2 84.42% 99.17%
CHEMBL5028 O14672 ADAM10 80.64% 97.50%

Cross-Links

Top
PubChem 31224
NPASS NPC208183
LOTUS LTS0045003
wikiData Q105183698